INSIGHTS ON SOLID DOSE MANUFACTURING
-
Low-Bioburden Powders For Terminal Sterilisation
Low‑bioburden powders for reconstitution demand strict microbial control, advanced formulation, and specialised manufacturing, making CDMO expertise vital for modern biopharma.
-
The Importance Of Tablet Density Uniformity
Non-uniform density causes many tablet failures. Learn how optimizing your formulation, tablet proportions, and tooling design ensures proper de-aeration for consistent quality.
-
Tablet And Capsule Inspection: Detecting Defects Before They Ship
Inline X-ray inspection identifies density variations and foreign contaminants in solid dose products to prevent costly recalls and ensure strict quality compliance.
-
Safely Scaling High Potency API Manufacturing
Scaling HPAPI production demands disciplined containment and exposure control. Integrated operating models help manage risk while enabling compliant, reliable scale‑up.
-
Ask Us Anything: Daniele Vigo On Cost-Effective Process Development7/23/2026
Daniele Vigo, Assistant Director at Cambrex Milan, on getting yield, purity, and scalability right without burning through the budget.
-
Tablet Logo Legibility: A Critical Component Of Consumer Health9/16/2026
Optimizing tablet debossing geometry balances regulatory legibility standards with compression efficiency, preventing sticking, picking, and film coating defects.
-
Ask Us Anything: Eric Fang On Lithiation Chemistry7/24/2026
Eric Fang, General Manager of Snapdragon Chemistry, on why lithiation chemistry resists batch scale-up — and how a decade spent understanding static mixing lets Snapdragon carry these reactions from milligrams to metric tons.
-
Overview Of Hot Melt Extrusion And Its Pharmaceutical Applications8/31/2026
More than 40% of NCEs face aqueous solubility challenges. Here, we examine how hot melt extrusion addresses solubility, modified release, abuse deterrence, and scale-up across pharmaceutical development.
-
Improving Bioavailability Through Predictive Modeling Of Solubility Enhancement Strategies7/15/2026
In silico modeling cut through formulation guesswork for a compound with 0.015 mg/mL solubility, delivering an 8× Cmax and 5× AUC improvement and Phase I progression.
SOLID DOSE MANUFACTURING SOLUTIONS
-
We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each individual program.
-
A facility overview highlighting solubility enhancement and advanced drug delivery capabilities, including a predictive formulation platform and project timeline benchmarks.
-
Forming part of 3P innovation’s Discover Range, this early-stage development unit uses two sets of die punches to compress pellets and seal them within a blister strip. Used predominantly for dry powder inhalers (DPIs), the ultra-compact filler fits on your lab benchtop.
-
When AST came to the table on the design for our new fill-finish isolator, one of the first areas AST engineers wanted to address was the usability and accessibility of the isolator and corresponding operations. With our customers’ point of view in mind, we wanted to address specific points of friction routinely encountered by operators and closely examine whether those friction points were necessary.
Does an isolator need to be ergonomically unfriendly to clean?
Should simple mechanisms like isolator doors be challenging to engage? (As much as one can appreciate exercise, no one wants to do “arm day” in cleanroom coveralls).
Does routine maintenance have to be time-consuming and laborious?
Many of these factors are accepted as par for the course in aseptic fill-finish manufacturing. Our question was, why?
-
Used Vector Freund roller compactor system, model TFC-LABO, stainless steel construction, approximately 50 mm roll diameter x 24 mm roll face width rolls, vertical compression screw with motor, with motor controllers for rolls and feed screw, rated 5 g-1 kg/hour production speed, with Vector oscillating granulator, serial# RC-266 46483, built 2008.